Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学RCC Belzutifan/HIF-2

Nizar Tannir

MD

🏢MD Anderson Cancer Center🌐USA

Professor, Department of GU Medical Oncology

72
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Nizar Tannir is a leading RCC investigator who has led pivotal immunotherapy and targeted therapy trials including studies of belzutifan in advanced RCC. His expertise in rare kidney cancer variants has expanded treatment options for underserved patient populations. He continues to drive clinical research on novel combination strategies in kidney cancer.

Share:

🧪Research Fields 研究领域

Renal cell carcinoma
Immunotherapy combinations
HIF pathway
Rare kidney cancers
Belzutifan

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Nizar Tannir 的研究动态

Follow Nizar Tannir's research updates

留下邮箱,当我们发布与 Nizar Tannir(MD Anderson Cancer Center)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment